Rep. Spanberger Seeks Additional Answers From DEA, FDA on Efforts to Stop Ongoing ADHD Medication Shortages
October 31, 2024
October 31, 2024
WASHINGTON, Oct. 31 -- Rep. Abigail Spanberger, D-Virginia, issued the following news release:
U.S. Representative Abigail Spanberger is urging the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) to provide additional answers on their work to end shortages of attention deficit hyperactivity disorder (ADHD) medications -- including Adderall.
On October 12, 2022, the FDA declared a shortage of amphetamine mixed salts, more commonly known by th . . .
U.S. Representative Abigail Spanberger is urging the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) to provide additional answers on their work to end shortages of attention deficit hyperactivity disorder (ADHD) medications -- including Adderall.
On October 12, 2022, the FDA declared a shortage of amphetamine mixed salts, more commonly known by th . . .